Candel Therapeutics Inc. Watch

from 8-K 12 pages Form of Pre-Funded Warrant to Purchase Common Stock

from S-3 40 pages Candel Therapeutics, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [•], 202[•] Subordinated Debt Securities

from S-3 39 pages Candel Therapeutics, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [•], 202[•] Senior Debt Securities

from 10-K 6 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as Amended

from S-1/A 20 pages Void After , 2023

from S-1/A 14 pages Advantagene, Inc. Warrant to Purchase Common Stock No. , 2018 Void After , 2023

from S-1/A 2 pages The Securities Represented Hereby Have Been Acquired for Investment and Have Not Been Registered Under the Securities Act of 1933. Such Shares May Not Be Sold, Pledged, or Transferred in the Absence of Such Registration or a Valid Exemption From the Registration and Prospectus Delivery Requirements of Said Act. the Securities Represented Hereby May Be Transferred Only in Accordance With the Terms of an Agreement Between the Company and the Stockholder, a Copy of Which Is on File With the Secretary of the Company

from S-1 10 pages Advantagene, Inc. Warrant to Purchase Series a Convertible Preferred Stock

from S-1 51 pages Certain Confidential Portions of This Exhibit Have Been Omitted and Replaced With “[***]”. Such Identified Information Has Been Excluded From This Exhibit Because It Is (I) Not Material and (II) Would Likely Cause Competitive Harm to the Company if Disclosed. Amended and Restated Investors’ Rights Agreement